Four years of tenofovir monotherapy for NUC naive field practice European patients suppresses HBV replication in most patients with a favorable renal safety profile but does not prevent HCC in patients with or without cirrhosis

Lampertico, P.;Soffredini, R.;Yurdaydin, C.;Idilman, R.;Papatheodoridis, G.v.;Margariti, E.;Buti, M.;Esteban, R.;Zaltron, S.;Vavassori, A.;Castelli, F.;Viganò, M.;Rumi, M.;Vinci, M.;Belli, L.s.;Cologni, G.;Rizzi, M.;Milanese, M.;Strazzabosco, M.;Minola, E.;Giorgini, A.m.;Zuin, M.;Salmi, A.;Colombo, S.;Fracassetti, O.;Del Poggio, P.;Bruno, S.;Fagiuoli, S.;Andreoletti, M.;Colli, A.;Colombo, A.e.;Bellati, G.a.;Magni, C.f.;Angeli, E.;Gubertini, Ga;FASANO, MASSIMO;SANTANTONIO, TERESA ANTONIA;Terreni, N.m.;Mangia, G.;Colombo, M.

2013-01-01